T cells in coronary artery disease

被引:6
作者
Aukrust, Pal [1 ]
Yndestad, Arne [1 ]
Sandberg, Wiggo J. [1 ]
Gullestad, Lars [1 ]
Damas, Jan K. [1 ]
机构
[1] Univ Oslo, Rikshosp Radiumhosp Med Ctr, Internal Med Res Inst, Dept Cardiol,Sect Clin Immunol, Oslo, Norway
关键词
D O I
10.1016/j.jacc.2007.06.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1459 / 1461
页数:3
相关论文
共 21 条
[1]   Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis -: Possible pathogenic role in plaque destabilization [J].
Damas, Jan K. ;
Smith, Camilla ;
Oie, Erik ;
Fevang, Borre ;
Halvorsen, Bente ;
Wæhre, Torgun ;
Boullier, Agnes ;
Breland, Unni ;
Yndestad, Arne ;
Ovchinnikova, Olga ;
Robertson, Anna-Karin L. ;
Sandberg, Wiggo J. ;
Kjekshus, John ;
Tasken, Kjetil ;
Froland, Stig S. ;
Gullestad, Lars ;
Hansson, Goran K. ;
Quehenberger, Oswald ;
Aukrust, Pal .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) :614-620
[2]   T lymphocytes in atherosclerosis - The yin-yang of Th1 and Th2 influence on lesion formation [J].
Daugherty, A ;
Rateri, DL .
CIRCULATION RESEARCH, 2002, 90 (10) :1039-1040
[3]   The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice [J].
Davenport, P ;
Tipping, PG .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (03) :1117-1125
[4]   Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes [J].
Freigang, S ;
Hörkkö, S ;
Miller, E ;
Witztum, JL ;
Palinski, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1972-1982
[5]   IFN-gamma potentiates atherosclerosis in apoE knock-out mice [J].
Gupta, S ;
Pablo, AM ;
Jiang, XC ;
Wang, N ;
Tall, AR ;
Schindler, C .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2752-2761
[6]   Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease [J].
Hansson, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1685-1695
[7]   Lnterferon-γ and atherosclerosis:: Pro- or anti-atherogenic? [J].
Harvey, EJ ;
Ramji, DP .
CARDIOVASCULAR RESEARCH, 2005, 67 (01) :11-20
[8]   Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells [J].
Heller, Eric A. ;
Liu, Emerson ;
Tager, Andrew M. ;
Yuan, Qian ;
Lin, Alexander Y. ;
Ahluwalia, Neil ;
Jones, Krister ;
Koehn, Stephanie L. ;
Lok, Vincent M. ;
Aikawa, Elena ;
Moore, Kathryn J. ;
Luster, Andrew D. ;
Gerszten, Robert E. .
CIRCULATION, 2006, 113 (19) :2301-2312
[9]  
Katznelson S, 1998, J HEART LUNG TRANSPL, V17, P335
[10]  
Liuzzo G, 2001, CIRCULATION, V103, P1509